Blueprint Medicines Corp Price History

BPMCDelisted Stock  USD 129.46  0.11  0.09%   
If you're considering investing in Blueprint Stock, it is important to understand the factors that can impact its price. As of today, the current price of Blueprint Medicines stands at 129.46, as last reported on the 2nd of August, with the highest price reaching 129.55 and the lowest price hitting 129.30 during the day. Blueprint Medicines appears to be very steady, given 3 months investment horizon. Blueprint Medicines Corp secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of risk over the last 3 months. By analyzing Blueprint Medicines' technical indicators, you can evaluate if the expected return of 0.53% is justified by implied risk. Please makes use of Blueprint Medicines' Downside Deviation of 1.37, mean deviation of 1.86, and Risk Adjusted Performance of 0.1647 to double-check if our risk estimates are consistent with your expectations.
  
Blueprint Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.1336

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsBPMC
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 3.97
  actual daily
35
65% of assets are more volatile

Expected Return

 0.53
  actual daily
10
90% of assets have higher returns

Risk-Adjusted Return

 0.13
  actual daily
10
90% of assets perform better
Based on monthly moving average Blueprint Medicines is performing at about 10% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Blueprint Medicines by adding it to a well-diversified portfolio.

Blueprint Medicines Stock Price History Chart

There are several ways to analyze Blueprint Stock price data. The simplest method is using a basic Blueprint candlestick price chart, which shows Blueprint Medicines price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Blueprint Stock Price History Data

The price series of Blueprint Medicines for the period between Sun, May 4, 2025 and Sat, Aug 2, 2025 has a statistical range of 48.62 with a coefficient of variation of 16.22. The prices are distributed with arithmetic mean of 110.9. The median price for the last 90 days is 104.64.
OpenHighLowCloseVolume
08/02/2025
 129.35  129.55  129.30  129.46 
07/17/2025 129.35  129.55  129.30  129.46  1.00 
07/16/2025
 129.34  129.65  129.20  129.28  25,678,550 
07/15/2025
 129.33  129.40  129.31  129.35  5,221,346 
07/14/2025 129.30  129.47  129.25  129.36  6,668,890 
07/11/2025
 129.32  129.35  129.00  129.30  3,570,356 
07/10/2025 129.49  129.49  129.23  129.33  5,983,948 
07/09/2025
 128.47  128.58  128.35  128.55  2,996,549 
07/08/2025 128.37  128.78  128.31  128.40  2,959,243 
07/07/2025
 128.31  128.44  128.22  128.40  1,858,051 
07/03/2025
 128.25  128.40  128.20  128.35  1,350,246 
07/02/2025
 128.35  128.45  128.20  128.20  2,317,947 
07/01/2025
 128.18  128.52  128.16  128.34  2,594,824 
06/30/2025
 128.30  128.32  128.08  128.18  2,350,220 
06/27/2025
 128.24  128.28  128.06  128.11  2,988,770 
06/26/2025
 128.29  128.31  128.10  128.15  2,529,566 
06/25/2025
 128.30  128.32  128.19  128.25  2,444,676 
06/24/2025
 128.40  128.40  128.15  128.26  3,377,048 
06/23/2025
 128.19  128.45  128.11  128.40  3,407,460 
06/20/2025
 128.27  128.30  128.00  128.20  4,506,151 
06/18/2025
 128.29  128.32  128.02  128.12  3,540,348 
06/17/2025 128.14  128.33  128.03  128.23  3,352,800 
06/16/2025
 128.05  128.30  127.86  128.25  5,148,159 
06/13/2025
 128.18  128.27  127.95  127.96  4,731,774 
06/12/2025
 128.03  128.26  127.94  128.21  4,653,922 
06/11/2025
 127.97  128.34  127.83  127.95  3,826,825 
06/10/2025
 127.95  128.10  127.75  127.97  4,462,710 
06/09/2025
 127.98  127.98  127.65  127.97  7,195,996 
06/06/2025
 128.07  128.07  127.77  127.85  3,067,543 
06/05/2025 128.10  128.24  127.83  127.90  4,454,501 
06/04/2025
 127.70  128.14  127.60  128.10  8,923,089 
06/03/2025 127.85  127.97  127.45  127.60  20,114,926 
06/02/2025
 128.01  128.15  127.43  127.79  46,416,832 
05/30/2025
 103.17  103.17  100.57  101.35  903,308 
05/29/2025
 95.32  103.16  94.38  103.06  1,413,002 
05/28/2025
 100.13  100.30  95.19  95.30  1,284,598 
05/27/2025
 102.52  102.52  99.95  100.06  709,966 
05/23/2025
 99.14  101.70  98.25  101.50  353,347 
05/22/2025
 101.00  101.75  99.65  100.34  487,838 
05/21/2025
 101.98  102.92  100.27  101.51  491,714 
05/20/2025
 100.99  103.15  96.15  103.00  448,916 
05/19/2025
 100.80  102.45  99.29  101.22  398,264 
05/16/2025
 100.05  102.18  99.38  101.69  581,639 
05/15/2025
 97.72  100.05  97.02  99.49  444,903 
05/14/2025
 99.46  100.38  97.49  97.51  424,300 
05/13/2025
 100.43  100.52  98.50  99.41  595,632 
05/12/2025
 97.65  101.97  97.40  100.31  717,805 
05/09/2025
 100.04  101.34  97.08  97.17  621,844 
05/08/2025
 99.13  101.17  97.91  98.76  796,704 
05/07/2025
 99.36  101.35  98.46  99.80  906,170 
05/06/2025
 100.75  103.63  99.01  99.16  1,543,226 
05/05/2025
 104.53  104.78  100.31  101.84  1,146,190 
05/02/2025
 99.25  104.86  98.60  104.64  1,514,066 
05/01/2025
 91.14  99.78  90.02  99.25  1,717,497 
04/30/2025
 88.21  89.99  87.03  89.50  1,106,571 
04/29/2025
 88.04  89.56  87.55  88.48  573,415 
04/28/2025
 86.34  89.19  85.70  88.51  786,733 
04/25/2025
 84.78  87.81  84.25  87.66  679,539 
04/24/2025
 86.07  86.84  84.90  86.09  762,848 
04/23/2025
 86.02  86.85  84.38  85.81  699,038 
04/22/2025
 84.50  85.41  83.27  83.41  919,993 

About Blueprint Medicines Stock history

Blueprint Medicines investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Blueprint is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Blueprint Medicines Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Blueprint Medicines stock prices may prove useful in developing a viable investing in Blueprint Medicines
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. Blueprint Medicines Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts. Blueprint Medicines operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 580 people.

Blueprint Medicines Stock Technical Analysis

Blueprint Medicines technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Blueprint Medicines technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Blueprint Medicines trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Share Portfolio Now

   

Share Portfolio

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Blueprint Medicines Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Blueprint Medicines' price direction in advance. Along with the technical and fundamental analysis of Blueprint Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Blueprint to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Consideration for investing in Blueprint Stock

If you are still planning to invest in Blueprint Medicines Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Blueprint Medicines' history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets